Vimpat 200 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FU5NM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,456
Award facts
- Contract value 100% obligated
- $3,455.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Vimpat 200 mg tablets in quantities of 60 units, with a firm fixed price ceiling value of $3,455.90. This delivery order represents a non-competitive, non-set-aside award and is scheduled for completion by August 21, 2025. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. Vimpat is a prescription antiepileptic medication used in the treatment of partial-onset seizures, reflecting the Defense Logistics Agency's ongoing pharmaceutical procurement needs for military healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp maintains an extensive portfolio of prescription medications and medical supplies supporting military and veteran healthcare programs globally. The parent contract serves as a comprehensive procurement vehicle enabling the company to supply an expansive range of brand-name and generic pharmaceuticals, vaccines, and specialized medical commodities across multiple therapeutic domains to support Defense Health Agency requirements and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FU5NM?
SPE2DB25FU5NM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 20, 2025.
How much is contract SPE2DB25FU5NM worth?
The government has obligated $3,456 on SPE2DB25FU5NM.
Is contract SPE2DB25FU5NM an order under another contract?
Yes. SPE2DB25FU5NM is a delivery order under SPE2DB22D2108, an indefinite delivery contract.
Was contract SPE2DB25FU5NM competed?
The extent of competition for SPE2DB25FU5NM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award